Physician profile
Mario E Tano
NPI 1174510341
$3,356.63
in general payments reported to CMS, 2019-2025
21 companies · $916 in 2025
The $916 reported for 2025 was more than what 81% of Pediatric Gastroenterology providers received nationally (typical 2025 total: $195).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $76.73 · 2020: $106 · 2021: $509 · 2022: $447 · 2023: $846 · 2024: $456 · 2025: $916.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,209 · Education: $9.24.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,208.69 |
| Education | $9.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $844.48 | 2019-2025 | Stelara, Simponi Aria, Simponi |
| Qol Medical, LLC | $558.59 | 2020-2025 | Sucraid, Sucraid |
| Genzyme Corporation | $525.04 | 2022-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $412.36 | 2021-2025 | Gattex, Eohilia |
| Abbvie INC. | $390.06 | 2019-2025 | |
| Ipsen Biopharmaceuticals, INC | $177.22 | 2024-2025 | Bylvay |
| Nestle Healthcare Nutrition INC. | $83.92 | 2021-2023 | |
| Amgen INC. | $67.23 | 2021-2023 | Avsola |
| Celltrion USA INC. | $48.72 | 2025 | Vegzelma |
| Boehringer Ingelheim Pharmaceuticals, INC. | $32.57 | 2023 | Cyltezo |
| Mirum Pharmaceuticals, INC. | $24.72 | 2023 | Livmarli |
| Phathom Pharmaceuticals, INC. | $23.83 | 2025 | Voquezna |
| Travere Therapeutics, INC. | $23.17 | 2023 | Cholbam |
| Capsovision, INC. | $22.72 | 2025 | Capsocam Plus |
| Albireo Pharma, INC. | $20.80 | 2023 | Bylvay |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aimmune Therapeutics, INC. | $20.65 | 2025 | Zenpep |
| Alexion Pharmaceuticals, INC. | $20.38 | 2019 | |
| Phadia US INC. | $19.60 | 2023 | Immunocap |
| Hologic Sales and Service, LLC | $17.90 | 2023 | Coolseal Generator |
| Medtronic, INC. | $13.43 | 2023 | Inpen Smart Insulin Delivery System |
| Janssen Pharmaceuticals, INC | $9.24 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mario Tano listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.